Entero Therapeutics, Inc. Annual Income Tax Expense (Benefit) in USD from 2015 to 2021

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Entero Therapeutics, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2015 to 2021.
  • Entero Therapeutics, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$14.9M.
  • Entero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2021 was $0.000.
  • Entero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2020 was $0.000.
  • Entero Therapeutics, Inc. annual Income Tax Expense (Benefit) for 2019 was $0.000.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Period Value YoY Chg Change % Start Date End Date Report Filed
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2022-03-31
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $0 Jan 1, 2019 Dec 31, 2019 10-K 2021-03-31
2017 $0 $0 Jan 1, 2017 Dec 31, 2017 10-K 2018-03-16
2016 $0 $0 Jan 1, 2016 Dec 31, 2016 10-K 2018-03-16
2015 $0 Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
* An asterisk sign (*) next to the value indicates that the value is likely invalid.